Business Context and Reporting Period
Company: E. I. du Pont de Nemours and Company (EIDP, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: May 3, 2007
Purpose: To restate historical segment information for 2004, 2005, and 2006 to align with new reporting structures effective January 1, 2007. The company realigned businesses within Agriculture & Nutrition, Performance Materials, and Other segments to better reflect growth platforms. Additionally, segment sales no longer include a pro rata share of equity affiliates' sales.
Key Financial Metrics (Restated)
All dollar amounts are in millions. The following data reflects the restated figures consistent with the 2007 presentation.
| Metric | 2006 | 2005 | 2004 |
|---|---|---|---|
| Total Net Sales | $27,421 | $26,639 | $27,340 |
| Total Segment Pretax Operating Income (PTOI) | $4,283 | $4,139 | $2,735 |
| Income Before Taxes & Minority Interests | $3,329 | $3,563 | $1,442 |
| Total Segment Net Assets | $19,722 | $18,556 | $19,455 |
| Total Assets | $31,777 | $33,291 | $35,632 |
| Depreciation & Amortization | $1,384 | $1,358 | $1,347 |
| Expenditures for Long-Lived Assets | $1,532 | $1,340 | $1,232 |
Note: Cash flow and debt figures are not explicitly provided in this filing text.
Material Changes vs. Prior Periods
- Segment Realignment Impact (2006): While total PTOI remained unchanged, the reallocation shifted income among segments: Agriculture & Nutrition increased by $97M; Coatings & Color Technologies increased by $22M; Electronic & Communication Technologies decreased by $12M; Performance Materials decreased by $68M; and Other increased its loss by $39M.
- Revenue Trend: Net sales increased by approximately 3% from 2005 ($26,639M) to 2006 ($27,421M), recovering to levels similar to 2004 ($27,340M).
- Profitability Trend: Segment PTOI grew from $2,735M in 2004 to $4,283M in 2006, driven by significant improvements in 2005 and 2006 compared to the heavy charges in 2004.
Unusual Items, Risks, and Management Commentary
Unusual Items and Charges (Pretax):
- 2006: Net charges of $181M. Key items included a $194M restructuring charge (Agriculture & Nutrition: $122M; Performance Materials: $72M), a $47M asset impairment in Safety & Protection, and a $58M charge due to transaction cutoff changes. These were partially offset by $61M in asbestos litigation insurance recoveries and $73M in technology transfer income.
- 2005: Net charges of $12M. Included $160M in hurricane-related costs (Coatings & Color Technologies: $116M) offset by gains from asset dispositions and insurance recoveries.
- 2004: Net charges of $1,470M. Dominated by a $667M charge related to the sale of INVISTA (Textiles & Interiors), $312M in severance benefits, and significant litigation charges including $268M for DDE antitrust matters and $108M for PFOA litigation.
Management Commentary: The company states the segment changes were made to align businesses with growth platforms to provide more opportunity for synergy and technology development. The Pharmaceuticals segment is limited to income from Cozaar and Hyzaar.
Investor Verification Checklist
- Verify the impact of the $194M restructuring charge in 2006 on future operating costs and cash flow.
- Confirm the status of asbestos litigation and the sustainability of the $61M insurance recovery benefit.
- Review the reconciliation of segment net assets to total assets to understand the composition of corporate assets ($5,876M in 2006), which includes pension assets under SFAS 158.
- Assess the volatility in the Electronic & Communication Technologies segment, which saw a decrease in PTOI due to realignment and historical litigation charges.
- Check subsequent filings for the actual 2007 Q1 results to compare against the new segment baseline.